Literature DB >> 18983837

Cystatin C for early detection of renal impairment in diabetes.

D Willems1, F Wolff, F Mekahli, F Mekhali, C Gillet.   

Abstract

OBJECTIVES: Evaluation of glomerular filtration rate is of crucial importance in diabetes. Cystatin C, a cysteine protease inhibitor seems to be an interesting parameter. DESIGN AND METHODS: 67 diabetic patients with normal creatinine are evaluated. Cystatin C is compared to renal markers, by reference to Cr EDTA clearance.
RESULTS: Significant correlations are found between cystatin C and creatinine (r=0.54). GFR MDRD (r=-0.47) and GFR Cr EDTA (r=-0.47). The AUC of the receiver operating curves is better for GFR MDRD (0.83) and cystatin C (0.75) than for creatinine (0.63) considering the cut off value of 80 mL/min for GFR EDTA.
CONCLUSION: Cystatin C seems to be a more sensitive parameter than creatinine for the detection of an incipient nephropathy in diabetes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18983837     DOI: 10.1016/j.clinbiochem.2008.10.002

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  10 in total

Review 1.  Advances in glomerular filtration rate-estimating equations.

Authors:  Lesley A Stevens; Smita Padala; Andrew S Levey
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-05       Impact factor: 2.894

2.  Serum cystatin C and prediabetes in non-obese US adults.

Authors:  Charumathi Sabanayagam; Tien Yin Wong; Jie Xiao; Anoop Shankar
Journal:  Eur J Epidemiol       Date:  2013-02-16       Impact factor: 8.082

3.  Reference intervals and factors contributing to serum cystatin C levels in a Chinese population.

Authors:  Dong-Dong Li; Meng-Na Zou; Xin Hu; Mei Zhang; Cheng-Yao Jia; Chuan-Min Tao; Lan-Lan Wang; Bin-Wu Ying
Journal:  J Clin Lab Anal       Date:  2012-02       Impact factor: 2.352

4.  Serum cystatin C and the incidence of hypertension in type 1 diabetes mellitus.

Authors:  Karine Sahakyan; Barbara E K Klein; Kristine E Lee; Michael Y Tsai; Ronald Klein
Journal:  Am J Hypertens       Date:  2010-09-30       Impact factor: 2.689

5.  Serum cystatin C and the incidence of type 2 diabetes mellitus.

Authors:  K Sahakyan; K E Lee; A Shankar; R Klein
Journal:  Diabetologia       Date:  2011-03-05       Impact factor: 10.122

6.  Effects of DPP-4 inhibitors on the heart in a rat model of uremic cardiomyopathy.

Authors:  Lyubov Chaykovska; Karoline von Websky; Jan Rahnenführer; Markus Alter; Susi Heiden; Holger Fuchs; Frank Runge; Thomas Klein; Berthold Hocher
Journal:  PLoS One       Date:  2011-11-18       Impact factor: 3.240

7.  Role of cystatin C in renal damage and the optimum cut-off point of renal damage among patients with type 2 diabetes mellitus.

Authors:  Xiaopang Rao; Meiyan Wan; Caixia Qiu; Chongcai Jiang
Journal:  Exp Ther Med       Date:  2014-06-30       Impact factor: 2.447

Review 8.  Chronic kidney disease screening methods and its implication for Malaysia: an in depth review.

Authors:  Yasmin Almualm; Hasniza Zaman Huri
Journal:  Glob J Health Sci       Date:  2015-01-01

9.  Simple cystatin C formula for estimation of glomerular filtration rate in overweight patients with diabetes mellitus type 2 and chronic kidney disease.

Authors:  Sebastjan Bevc; Radovan Hojs; Robert Ekart; Matej Završnik; Maksimiljan Gorenjak; Ludvik Puklavec
Journal:  Exp Diabetes Res       Date:  2012-09-12

10.  The Association of Serum Cystatin C with Glycosylated Hemoglobin in Korean Adults.

Authors:  Eun Hee Sim; Hye Won Lee; Hyun Ju Choi; Dong Wook Jeong; Seok Man Son; Yang Ho Kang
Journal:  Diabetes Metab J       Date:  2016-02       Impact factor: 5.376

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.